Drug Information
	Drug 1	Drug 2
Generic/working name	Cabozantinib	Avelumab
Company name	Exelixis	Merck, and Pfizer
Drug type	Small-molecule inhibitor	Monoclonal antibody
Drug class	Tyrosine kinase inhibitor	Programmed death-ligand 1 inhibitor
Dose	20, 40, and 60 mg/day	10 mg/kg every 2 weeks
Unit	mg/day	mg/kg
Route	Oral	Intravenous (i.v.)
Schedule of Administration	Every day	Every 2 weeks